RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.

BMC Cancer · 2009 · PMC2749868 · PMID 19725960

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the combined therapy slightly increased the median overall survival of the total study population to 17.6 months as compared to 14.6 in the EORTC26981/NCIC-CE.3 study [ 2 ], this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.